Oscar Health (OSCR) Stock Forecast: What Could Drive It in 2026
Short answer
What is actually driving Oscar Health (OSCR) right now is Membership growth and share gains: Oscar grew to about 3.2 million members in early 2026, roughly 56% higher than a year earlier, expanding faster than the overall ACA marketplace. Revenue (TTM) is ~$13 billion. If that keeps playing out, the setup is favourable; the risk to it is the dominant risk is policy. No one can predict where OSCR trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.
What could drive Oscar Health (OSCR) higher?
1. Membership growth and share gains
Oscar grew to about 3.2 million members in early 2026, roughly 56% higher than a year earlier, expanding faster than the overall ACA marketplace. Each net-new member adds premium revenue, and the company has entered new states and counties to widen its footprint. The bet is that a simpler digital experience keeps winning enrollees from legacy carriers.
2. Turn to profitability
After years of losses, Oscar reached record profitability, reporting Q1 2026 net income near $679 million and an improving medical loss ratio of about 70.5%, down roughly 490 basis points year over year. Management reaffirmed full-year guidance for earnings from operations of $250 million to $450 million. Sustained profit, if it holds through the seasonally heavier back half, is the core of the re-rating story.
3. The +Oscar technology platform
Beyond selling insurance, Oscar licenses its +Oscar technology stack (claims automation, member engagement, care navigation) to other healthcare organizations. This platform revenue is still a small slice but grows faster than premiums and carries higher margins, giving Oscar a second, less capital-intensive line that is not purely a bet on the ACA marketplace.
4. Operating leverage and automation
Oscar leans on automation, citing very high claims auto-adjudication rates, to run leaner than traditional insurers. Its SG&A ratio improved toward roughly 15% as membership scaled. If it can keep administrative costs falling as a share of revenue while enrollment grows, incremental premium dollars should convert to profit at a higher rate than for slower peers.
What could weigh on OSCR?
The dominant risk is policy. Oscar is a near pure-play ACA marketplace insurer, so the scheduled expiration of enhanced federal premium tax credits is an existential-level variable: if the credits are not extended, marketplace premiums could more than double for many enrollees, healthier members may drop coverage, and the remaining risk pool would skew sicker and more expensive. Oscar itself took a weighted-average rate increase near 28% for 2026 partly to account for worsening morbidity. Results are also highly seasonal and can be volatile, swinging from strong first-quarter profit to losses later in the year as the medical loss ratio climbs; full-year MLR is guided well above the Q1 figure. On top of that, Oscar competes against far larger, better-capitalized insurers, and any spike in medical costs, adverse regulatory change, or execution stumble hits a company still proving it can stay consistently profitable.
Where OSCR trades today
A forecast starts from where the stock actually is. These are OSCR's current figures, not a projection: the drivers and risks above are what would move them.
Snapshot for OSCR as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
How to think about a OSCR forecast
Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.
For the full picture, see the OSCR guide and whether OSCR is a buy. In Walnut you can pressure-test the thesis against your real portfolio.
The bottom line on the OSCR outlook
The bottom line: what is driving Oscar Health (OSCR) is Membership growth and share gains, with revenue (ttm) at ~$13 billion. If that keeps playing out the setup is favourable; the risk is the dominant risk is policy. No one can predict the price, so treat any OSCR forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.
Build a basket around OSCR with Walnut
Use Oscar Health as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the forecast for Oscar Health (OSCR)?
+
No one can reliably predict where OSCR will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push Oscar Health higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.
What could drive OSCR higher?
+
The main growth drivers are Membership growth and share gains; Turn to profitability; The +Oscar technology platform. Whether they play out is the real question, not a guaranteed path.
What are the risks to OSCR?
+
The dominant risk is policy. Oscar is a near pure-play ACA marketplace insurer, so the scheduled expiration of enhanced federal premium tax credits is an existential-level variable: if the credits are not extended, marketplace premiums could more than double for many enrollees, healthier members may drop coverage, and the remaining risk pool would skew sicker and more expensive. Oscar itself took a weighted-average rate increase near 28% for 2026 partly to account for worsening morbidity. Results are also highly seasonal and can be volatile, swinging from strong first-quarter profit to losses later in the year as the medical loss ratio climbs; full-year MLR is guided well above the Q1 figure. On top of that, Oscar competes against far larger, better-capitalized insurers, and any spike in medical costs, adverse regulatory change, or execution stumble hits a company still proving it can stay consistently profitable.
Will OSCR stock go up in 2026?
+
Nobody knows, and anyone who says they do is guessing. Oscar Health's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.
Is OSCR a buy?
+
That depends on your thesis, time horizon, and what you already own, not on a forecast. See the OSCR "is it a buy?" page for a framework. Walnut is not an investment adviser.
Why did OSCR stock rise so much in 2026?
+
The stock roughly doubled in 2026 after Oscar reported a record first quarter, with revenue up more than 50% year over year, net income near $679 million, and an improving medical loss ratio. Membership surged about 56%, and management reaffirmed full-year profit guidance. Optimism about a possible extension of ACA subsidies also lifted the shares on several occasions.
Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.